|
| Press Releases |
|
 |
|
| Tuesday, August 19, 2025 |
|
|
康哲藥業（867.HK，8A8.SG）上半年營收淨利雙升 戰略轉型跑出增長新動能 |
| 康哲藥業發佈2025年中期業績，公司營收和利潤同比均實現增長，戰略轉型成效初顯。報告期內，公司實現營業收入約40.0億元（人民幣，下同），同比增長10.8%。 more info >> |
|
|
康哲药业（867.HK，8A8.SG）上半年营收净利双升 战略转型跑出增长新动能 |
| 康哲药业发布2025年中期业绩，公司营收和利润同比均实现增长，战略转型成效初显。报告期内，公司实现营业收入约40.0亿元（人民币，下同），同比增长10.8%。 more info >> |
|
| Tuesday, July 29, 2025 |
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) ("ZUNVEYL" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
|
China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China |
| China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 28 July 2025, the New Drug Application (NDA) for improved new drug ZUNVEYL (Benzgalantamine Gluconate Enteric-coated Tablets) ("ZUNVEYL" or the "Product") has been accepted by the National Medical Products Administration of China (NMPA). more info >> |
|
| Tuesday, July 22, 2025 |
|
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets |
| On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Board of the Singapore Exchange ("SGX"), SGX and CMS co-hosted the "Singapore and Emerging Markets Pharmaceutical Industry Growth Forum & CMS SGX Secondary Listing Appreciation Dinner". more info >> |
|
| Friday, July 18, 2025 |
|
|
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索 |
| 2025年7月15日，值此康哲药业控股有限公司（"康哲药业"或"集团"）成功于新加坡交易所（"新交所"）主板二次上市之际，由新交所与康哲药业联合主办的"新加坡及新兴市场医药产业发展论坛暨康哲药业新交所二次上市答谢晚宴"在集团位于新加坡大士的CDMO生产工厂PharmaGend盛大举行。 more info >> |
|
| Tuesday, July 15, 2025 |
|
|
耀啟新程！康哲藥業今日於新加坡交易所主板實現二次上市 |
| 康哲藥業控股有限公司（「康哲藥業」或「集團」）在新加坡交易所正式鳴鑼上市（證券簡稱：CMS，股票代碼：8A8）。 more info >> |
|
|
耀启新程！康哲药业今日于新加坡交易所主板实现二次上市 |
| 康哲药业控股有限公司（“康哲药业”或“集团”）在新加坡交易所正式鸣锣上市（证券简称：CMS，股票代码：8A8）。 more info >> |
|
| Wednesday, June 25, 2025 |
|
|
康哲药业建议于新加坡交易所第二上市 |
| 康哲药业控股有限公司（以下简称“康哲药业”）之董事会宣布，建议将其普通股（“股份”）以介绍方式于新加坡证券交易所有限公司（“新交所”）作第二上市（“建议第二上市”）。 more info >> |
|
|
康哲藥業建議於新加坡交易所第二上市 |
| 康哲藥業控股有限公司（以下簡稱「康哲藥業」）之董事會宣佈，建議將其普通股（「股份」）以介紹方式於新加坡證券交易所有限公司（「新交所」）作第二上市（「建議第二上市」）。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 22:30: JST
|
|
|
CMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
Feb 24, 2026 21:30 HKT/SGT
|
|
|
TANAKA to Provide Medals for the Tokyo Marathon 2026 That Represent All the Participants in the Event with Woven Lines
Feb 24, 2026 22:00 JST
|
|
|
康哲藥業（867.HK/8A8.SG）：創新藥磷酸蘆可替尼乳膏增加特應性皮炎（AD）適應症中國上市許可申請獲受理並獲納入優先審評
Feb 24, 2026 20:31 HKT/SGT
|
|
|
康哲药业（867.HK/8A8.SG）：创新药磷酸芦可替尼乳膏增加特应性皮炎（AD）适应症中国上市许可申请获受理并获纳入优先审评
Feb 24, 2026 20:19 HKT/SGT
|
|
|
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
Feb 24, 2026 19:22: JST
|
|
|
Mitsubishi Shipbuilding Ships First Units of Systems for Marine Ammonia-Fueled Engines
Feb 24, 2026 20:07 JST
|
|
|
MHI Unveils "DIAVAULT," a Secure, High Performance Edge Data Center Platform
Feb 24, 2026 19:55 JST
|
|
|
CanSinoBIO's Menhycia (R) Secures Expanded Age Indication, Unlock Broader Long-Term Growth Potential
Feb 24, 2026 18:22 HKT/SGT
|
|
|
康希諾生物曼海欣(R)擴齡正式獲批 為公司長期價值開啟更廣闊發展空間
Feb 24, 2026 18:15 HKT/SGT
|
|
|
康希诺生物曼海欣(R)扩龄正式获批 为公司长期价值开启更广阔发展空间
Feb 24, 2026 18:08 HKT/SGT
|
|
|
迦里仕人才與耐吉澳門分公司續簽五年戰略合作協議 深化長期夥伴關系 夯實高端客戶基本盤
Feb 24, 2026 15:11 HKT/SGT
|
|
|
五一视界x摩尔线程：新一代仿真与GPU完成适配 共筑全栈国产化物理AI底座
Feb 24, 2026 13:38 HKT/SGT
|
|
|
Galaxy Payroll Group Renews Five-Year Strategic Cooperation Agreement with NIKE China Holding HK Limited (Macau Branch)
Feb 24, 2026 13:25: JST
|
|
|
五一視界x摩爾線程：新一代仿真與GPU完成適配 共築全棧國產化物理AI底座
Feb 24, 2026 13:21 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
